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Objectives: The purpose of this study was to evaluate the relation-
ship between clinical and radiological findings and the progression of 
ground-glass opacity (GGO) and to identify risk factors that predict 
the outcome of pure GGO lesions.
Methods: A retrospective study was conducted on 63 nodules of pure 
GGO. Clinical characteristics, the largest diameter, shape, and mar-
ginal characteristics, and one-dimensional mean computed tomog-
raphy (m-CT) value of the GGO lesions were evaluated. During 
follow-up, 12 GGO lesions increased in size, and 17 appeared as 
solid portion. These 29 lesions were classified as growth group, and 
the remaining 34 lesions as stable group.
Results: The m-CT values were −634.9 ± 15.3 and −712.1 ± 14.1 HU 
for the growth and stable groups, respectively. The growth group was 
strongly associated with high m-CT values (p = 0.0007) and a history 
of lung cancer (p = 0.0389), whereas association with smoking habits 
and the shape of the GGO nodules was marginal. The m-CT values 
and a history of lung cancer were independent predictors for future 
changes in GGO lesions (p = 0.0023 and p = 0.0129, respectively). 
Sixteen of 18 lesions (88.9%) in patients without a history of lung 
cancer and with low m-CT values showed no nodule changes.
Conclusions: The m-CT value of GGO lesions is a risk factor asso-
ciated with their future change. The interval of follow-up CT scan-
ning or treatment policy should be determined considering the m-CT 
value.
Key Words: Ground-glass opacity, Radiological features, Mean 
computed tomography
(J Thorac Oncol. 2014;9: 469–472)
With recent advancement in diagnostic imaging tech-nologies, ground-glass opacity (GGO) lesions are 
increasingly detected on high-resolution computed tomog-
raphy (HRCT) scans.1,2 GGO is defined as a shadow that is 
completely occupied by a hazy increased attenuation of the 
lung, with preservation of the bronchial and vascular lesion 
margins when assessed with HRCT.3 Many radiological stud-
ies of small lung adenocarcinomas have demonstrated a strong 
correlation between CT findings and pathological features, but 
few have demonstrated the outcome of pure GGO lesions in 
patients in whom some lesions are not resected and then fol-
lowed by CT scans. Therefore, the appropriate treatment strat-
egies for small tumors displaying GGO remain controversial. 
The objectives of this study were to determine the relationship 
between the clinical and radiological findings and the progress 
of GGO to predict the outcome of pure GGO lesions.
PATIENTS AND METHODS
Patients
This study was approved by our hospital’s internal review 
board. Between October 2008 and October 2012, a total 63 
nodules with GGO in consecutive 53 patients were followed 
up. Patients with localized and pure GGO without any solid 
component were included in this study, and those with GGO 
with a solid component were excluded. Medical records were 
retrospectively reviewed to investigate the clinical character-
istics, GGO features, histopathological results, and follow-up 
outcomes. All patients were followed up in accordance with 
the follow-up criteria for lung cancer CT screening guideline.4
Image Acquisition and Analysis
CT scans were performed from the lung apex to base 
during breath holding at mid-inspiration by using a CT scan-
ner with a section thickness of 2 mm (Asteion 4, Toshiba, 
Tokyo, Japan). Two radiologists with 19 and 10 years of 
experience in general radiology independently viewed these 
images and subjectively classified the nodules. Pure GGO was 
defined as a shadow completely occupied by a hazy increased 
attenuation of the lung, with preservation of the bronchial 
and vascular margins of the lesion with no solid regions on 
HRCT. The longest diameters of the GGO lesions were mea-
sured, and the shapes were classified as round and others (oval 
or polygonal). The marginal characteristics were classified 
as smooth and others (lobulated and speculated). Maximum 
diameter and one-dimensional mean CT (m-CT) value of this 
diameter were measured using a computer graphics support 
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system (Synapse PACS, Fujifilm, Tokyo, Japan). The shape of 
the region of interest was standardized for each patient and 
configured by freehand drawing. The interobserver variation 
was corrected by calculating the mean value of two observers.
Definitions of Malignant Findings
Lesion size was defined as the maximal diameter on 
HRCT and an increase in diameter of more than 2 mm, or an 
emerging solid portion was defined as a malignant radiological 
finding. We defined these lesions as growth group and others 
as stable group. The lesions that had a history of previous lung 
cancer were followed up by the surgeons and those that were 
discovered as part of CT screening were followed up by the 
pulmonologists. Radiologists and physicians performed care-
ful and close monitoring to determine whether GGO lesions 
had any malignant radiological findings. Histological findings 
of adenocarcinoma were classified according to the criteria of 
the World Health Organization.5
Statistical Analysis
All data regarding continuous variables are expressed 
as mean ± SD. Significant differences were assessed using the 
t test for continuous variables, and the χ2 test for categorical 
variables. Analyses were performed using the SAS software 
package (SAS Institute, Inc., Cary, NC). A p value less than 
0.05 was considered statistically significant.
RESULTS
Patient characteristics and GGO features are sum-
marized in Table 1. A total 63 lesions were detected in 53 
patients. Of these, one lesion was detected in 46 patients, 
two in four, and three in three. The mean age at diagnosis 
was 70.8 ± 9.3 years (range, 40–87 years). Twenty-three 
lesions were found in men and 40 in women. The mean size 
of GGO lesions at initial detection was 11.4 ± 4.2 mm (range, 
3.8–19.6 mm). Thirty-nine patients (61.9%) had no history 
of smoking. Twenty-four lesions had a history of previous 
lung cancer, and 39 were discovered as part of CT screening. 
The average follow-up period for all patients was 26.1 ± 4.6 
months. During the follow-up, 12 GGO lesions increased 
in size and 17 appeared as solid portion. These 29 lesions 
were classified as the growth group and the remaining 34 
lesions as the stable group. During the follow-up period, 45 
lesions were resected and pathologically diagnosed as ade-
nocarcinoma in situ (AIS; 38 lesions), minimally invasive 
adenocarcinoma (5), and invasive adenocarcinoma (papil-
lary predominant; 2). m-CT values were −634.9 ± 15.3 HU in 
the growth group and −712.1 ± 14.1 HU in the stable group 
(p = 0.0005) (Fig. 1). Prediction of the GGO change was 
attempted based on the m-CT value, and receiver operating 
characteristics curve analysis was performed to determine 
the appropriate cutoff value. The maximum sensitivity and 
specificity were obtained at a cutoff value of −677 HU. The 
mean interval from the first detection of GGO to the last 
observation was 28.6 ± 4.5 months for the growth group and 
24.2 ± 4.0 months for the stable group (p = 0.3366). Table 2 
shows the comparison of clinico–radiological data between 
lesions in the stable group and those in growth groups. The 
growth group was strongly associated with a high CT attenu-
ation value (p = 0.0007) and the growth group was associated 
with a history of lung cancer (p = 0.0389), whereas smoking 
habit and the shape of GGO nodules were marginally signifi-
cant (p = 0.0632 and p = 0.0725, respectively). Table 3 shows 
the results of multivariate analysis for predictors of changes 
in GGO lesions. m-CT value and a history of lung cancer 
were independent predictors (p = 0.0023 and p = 0.0129, 
respectively). A comparative distribution of the m-CT val-
ues between with and without a history of lung cancer is 
presented in Figure 2. Sixteen of 18 lesions (88.9%) in those 
without a history of lung cancer and with low m-CT values 
showed no change during the follow-up.
TABLE 1.  Clinical Characteristics of Patients and 63 GGO 
Lesions
Characteristics n
No. of patients 53
Total no. of GGO lesions 63
No. of GGO lesions per patient
  1 46
  2 4
  3 3
Age at diagnosis (yrs, mean ± SD) 70.8 ± 9.3 (40–87)
Male:female 23:40
History of smoking
  Nonsmoker 42
  Smoker 21
History of previous lung cancer
  No 39
  Yes 24
Size of GGO lesions (mm: mean ± SD [range]) 11.4 ± 4.2 (3.8–19.6)
GGO, ground-glass opacity.
FIGURE 1.  Comparison of the mean CT values between the 
growth and stable groups.
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DISCUSSION
The present study aimed to identify the risk factors 
associated with future changes in GGO lesions. Evaluation of 
various CT features, such as the m-CT values and, contour, a 
history of lung cancer, and smoking habits, can be helpful in 
predicting their future change. In particular, we initially dem-
onstrated the m-CT value of the GGO lesion as a recent risk 
factor. Therefore, it may be possible to resect GGO lesions 
before they grow so that the formation of invasive lesions can 
be prevented.
There may be two subgroups of GGO lesions, one that 
requires treatment and another that can be observed for a long 
time. Although some patients remain invariant for 5 to 10 
years, others present with the emergence of a solid compo-
nent or an increase of apparent size within 6 months. When 
GGO lesions are found in patients with otherwise operable 
non–small-cell lung cancer, decision making on these lesions 
becomes difficult.6 Nevertheless, it is controversial whether 
these lesions should be promptly resected during surgery for 
the primary tumor or should be followed up after the surgery.
Because GGO is a nonspecific finding, it can be caused by 
various diseases such as inflammation, fibrosis, or neoplasms.3 
In particular, with regard to pure GGO, the possibility of AIS 
(pure lepidic pattern) cannot be excluded. Kim et al.7 reported 
that approximately 75% persistent nodules were AIS. The 
remaining 25% nodules were attributed to atypical adenomatous 
hyperplasia (AAH) and nonspecific fibrous or organizing pneu-
monia.7,8 Clinically, GGO lesions that show the emergence of a 
solid component or apparent growth are indications for resec-
tion. In our study, the 29 lesions that revealed increased growth 
were resected and pathologically diagnosed as malignant.
This study identified a novel risk factor for GGO lesions 
associated with malignancy. Haro et al.9 reported that GGOs 
emerging after the resection of primary NSCLC have a signifi-
cantly increased risk of malignancy. A comparison of various 
CT features such as contour, margins, and the internal charac-
teristics of pulmonary nodules with pathological specimens can 
be helpful for developing criteria to distinguish between cancers 
and benign lesions.10–13 Our results showed that the tumor size, 
margins, and shape of nodules were not useful for differentiat-
ing between stable and growing GGO lesions. Nakata et al.14 
reported that all lesions larger than 10 mm were carcinomas, 
without exception. However, in the current study, even those 
lesions that were 10 mm or smaller in size showed growth ten-
dency. Therefore, it may be better to consider excision of lesions 
that were 10 mm or smaller in size, even if they have high m-CT 
values. Recently, Matsuguma et al.15 showed that the factors 
associated with growth are the type of subsolid nodule, initial 
nodule size, and history of lung cancer. Our data indicated that 
m-CT value and a history of lung cancer were independent pre-
dictors and m-CT value was superior to a history of lung cancer.
Many radiological studies of small lung adenocarci-
nomas have demonstrated a strong correlation between CT 
findings and pathological features. Several authors have classi-
fied small lung lesions into nonsolid (pure) GGO, partly solid 
(mixed) GGO, and solid types. However, it is sometimes diffi-
cult to differentiate between pure and mixed GGO, and between 
high-density GGO and solid tumor, no definite radiological 
TABLE 2.  Comparison of Clinico–Radiological Data between 
Lesions in Stable and Growth Categories
Factors Stable (n) Growth (n) p Value
Sex 0.2051
  Male 10 13
  Female 24 16
Age 0.3447
  <65 yrs 6 8
  ≥65 yrs 28 21
Lesion size 0.4408
  <10 mm 12 13
  ≥10 mm 22 16
Involvement 0.5467
  Absent 19 14
  Present 15 15
History of lung cancer 0.0389
  Without 25 14
  With 9 15
Smoking habit 0.0632
  Never 26 16
  Ever 8 13
No. of lesions 0.0971
  Solitary 20 11
  Multiple 14 18
Shape 0.0725
  Round 25 15
  Others 9 14
Margin 0.1053
  Smooth 21 12
  Irregular 13 17
Attenuation value (HU) of CT 0.0007
  <−677 27 11
  ≥−677 7 18
TABLE 3.  Multivariate Analysis for Predictors for Change of GGO Lesions
Factors
Category Odds Ratio (95% CI)
p ValueUnfavorable/favorable
Smoking habit Ever/never 1.729 (0.515–1.943) 0.1141
History of lung cancer With/without 3.191 (1.488–5.790) 0.0129
Attenuation value (HU) of computed tomography More than or equal to −677 or less than −677 7.572 (2.021–8.102) 0.0023
CI, confidence interval.
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criteria exist to distinguish these differences. Some authors 
used quantitative densitometric methodologies to evaluate 
GGO lesions.11,16–18 Ikeda et al.16 reported that the 75th percen-
tile CT value of GGO lesions, analyzed with  three-dimensional 
computerized quantification, was optimum for differentiating 
between AAH, AIS, and adenocarcinoma. In addition, they 
reported that a CT cutoff value of −584 HU was optimal for 
differentiating between AAH and AIS, whereas −472 HU was 
best for distinguishing AIS from adenocarcinoma.16 A clear-
cut diagnosis will be possible using m-CT values, because it 
is an objective criterion. In the presented study, although the 
sample size was small, most lesions without a history of lung 
cancer and with an m-CT of −677 HU or lower showed no 
change. Therefore, observation may be indicated for this type 
of GGO lesion. Further estimate validation is desired if these 
results will be applied to another cohort.
This study has several limitations. First, it was performed 
as a retrospective review. Second, although we included all 63 
lesions with GGO nodules, this is still a smaller sample size. 
Third, the follow-up duration was rather short, even though 
the mean interval from first detection of GGO to last observa-
tion between two groups showed no differences (p = 0.3366).
In conclusion, the evaluation of m-CT value is useful 
in determining the follow-up or resection for GGO. A future 
prospective study should be conducted to establish the optimal 
CT follow-up program and to evaluate its efficacy.
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FIGURE 2.  Relationship between mean CT value and a  
history of lung cancer.
